Autonomic Nervous System Drugs Practice Questions

Q: Which selective alpha-2 agonist is used in the treatment of glaucoma?

Brimonidine. ***Brimonidine*** - **Brimonidine** is an **alpha-2 adrenergic agonist** specifically designed for use in glaucoma treatment [1]. - It works by reducing **aqueous humor production** and increasing **uveoscleral outflow**, thereby lowering intraocular pressure [1]. *Timolol* - **Timolol** is a **non-selective beta-blocker** used in glaucoma to reduce **aqueous humor production**. - It does not primarily act as an alpha-2 agonist and has a different mechanism of action. *Epinephrine* - **Epinephrine** is a **non-selective adrenergic agonist** with both alpha- and beta-receptor activity. - While it can lower intraocular pressure, its broad effects and potential side effects make it less suitable as a first-line agent, and it is not a selective alpha-2 agonist. *Dipivefrine* - **Dipivefrine** is a **prodrug of epinephrine** that is converted to epinephrine within the eye. - Like epinephrine, it is a non-selective adrenergic agonist and not a selective alpha-2 agonist.

Q: In primary open-angle glaucoma, pilocarpine eye drops lower intraocular pressure primarily by acting on which of the following?

Longitudinal fibres of the ciliary muscle. ***Longitudinal fibres of the ciliary muscle***- Pilocarpine is a **muscarinic agonist** that contracts the **longitudinal fibers of the ciliary muscle** [1, 3].- This contraction pulls on the **scleral spur**, separating the **trabecular meshwork** sheets, which increases conventional **aqueous humor outflow** [2, 3].*Trabecular meshwork*- While the **trabecular meshwork** is the site where aqueous humor exits the eye, pilocarpine primarily acts on the ciliary muscle to **indirectly affect** the meshwork's outflow facility [2, 3].- Pilocarpine does not directly alter the structure or function of the trabecular meshwork cells.*Ciliary epithelium*- The **ciliary epithelium** is responsible for **aqueous humor production** [1, 2].- Pilocarpine primarily affects **outflow**, not production, through its action on the ciliary muscle [1, 2].*All of the options*- Pilocarpine does not act on **all** these structures; its primary mechanism is through the ciliary muscle to enhance outflow.- It has no direct significant effect on **ciliary epithelium** or direct action on the **trabecular meshwork** itself.

Q: Hyoscine is an antagonist at which cholinergic receptor?

Muscarinic. ***Muscarinic*** - **Hyoscine** (scopolamine) is a well-known **antagonist** at **muscarinic cholinergic receptors**. - It blocks the action of **acetylcholine** at these receptors, leading to its anticholinergic effects like treating motion sickness and reducing secretions. *Nicotinic* - **Hyoscine** does not primarily act on **nicotinic cholinergic receptors**. - Drugs acting on nicotinic receptors include **neuromuscular blockers** (e.g., succinylcholine, rocuronium) and **ganglionic blockers**, which have different clinical applications. *Both* - While some drugs may have activity at both receptor types, **hyoscine's primary and clinically significant antagonism is at muscarinic receptors**. - Its therapeutic effects are attributed almost exclusively to its **muscarinic blockade**. *None of the above* - This option is incorrect because **hyoscine is a clear antagonist at muscarinic cholinergic receptors**. - Its widespread use in medicine is based on this specific pharmacological action.

Q: Which sympathomimetic drug is primarily known to increase heart rate?

Isoprenaline. ***Isoprenaline*** - **Isoprenaline** (isoproterenol) is a non-selective beta-adrenergic agonist, with a strong affinity for **β1 and β2 receptors** [1]. - Its activation of **β1 receptors** in the heart leads to a significant increase in **heart rate (positive chronotropy)** and contractility (positive inotropy) [1]. - It is the **most potent chronotropic agent** among sympathomimetics and is primarily known for increasing heart rate [2]. *Phenylephrine* - **Phenylephrine** is a selective **α1 adrenergic agonist** that causes vasoconstriction [4]. - It increases blood pressure but typically causes **reflex bradycardia** (decreased heart rate) due to baroreceptor activation. - Does NOT directly increase heart rate. *Noradrenaline* - **Noradrenaline** (norepinephrine) primarily acts on **α1 receptors** causing vasoconstriction, and to a lesser extent on **β1 receptors** [3]. - While it can stimulate β1 receptors, its predominant effect is to increase **mean arterial pressure** through vasoconstriction, often causing **reflex bradycardia** [3]. *Adrenaline* - **Adrenaline** (epinephrine) acts on **α1, β1, and β2 receptors** [4]. While it does increase heart rate via **β1 receptor** stimulation, it also causes significant **vasoconstriction** (via α1) and **vasodilation** (via β2). - Its cardiovascular effects are more complex and dose-dependent compared to isoprenaline's specific chronotropic action.

Q: Which non-selective beta-blocker has sympathomimetic activity?

Pindolol. ***Pindolol*** - **Pindolol** is a **non-selective beta-blocker** that exhibits **intrinsic sympathomimetic activity (ISA)**, meaning it acts as a partial agonist at beta-adrenergic receptors. - Due to ISA, it causes less reduction in resting heart rate and cardiac output compared to beta-blockers without ISA. *Acebutalol* - **Acebutalol** is a **beta-1 selective blocker** (cardioselective) that possesses **intrinsic sympathomimetic activity (ISA)**. - While it has ISA, it is not a non-selective beta-blocker, making it an incorrect answer for this question. *Nadolol* - **Nadolol** is a **non-selective beta-blocker** that does **not** have intrinsic sympathomimetic activity (ISA). - It primarily acts as a pure antagonist at both beta-1 and beta-2 adrenergic receptors. *Metoprolol* - **Metoprolol** is a **beta-1 selective blocker** (cardioselective) and does **not** possess intrinsic sympathomimetic activity (ISA). - Its primary action is blockade of cardiac beta-1 receptors.

Q: Which anti-cholinesterase drug is known for its central nervous system activity?

Physostigmine. ***Physostigmine*** - Unlike most other anti-cholinesterases, **physostigmine** is a **tertiary amine** and is relatively lipid-soluble, allowing it to cross the **blood-brain barrier**. [2] - Its ability to increase acetylcholine in the CNS makes it useful in treating anticholinergic toxicity (e.g., atropine overdose). [2] *Pyridostigmine* - **Pyridostigmine** is a **quaternary amine** and does not readily cross the blood-brain barrier, primarily acting peripherally. - It is mainly used in the long-term management of **myasthenia gravis**. *Edrophonium* - **Edrophonium** is a very short-acting **quaternary amine** that does not cross the blood-brain barrier. [1] - It is primarily used for the **diagnosis of myasthenia gravis** (Tensilon test) due to its rapid onset and short duration of action. [1] *Neostigmine* - **Neostigmine** is also a **quaternary amine** with poor lipid solubility, meaning it has minimal central nervous system activity. [2] - It is commonly used to reverse the effects of **non-depolarizing neuromuscular blockers** and in the treatment of **myasthenia gravis**.

Q: Which of the following is an action of muscarinic cholinergic receptors?

Decreased heart rate. ***Decreased heart rate*** - Activation of **muscarinic cholinergic receptors (M2 receptors)** in the heart leads to a decrease in heart rate and conduction velocity. - This effect is mediated by the **vagus nerve (parasympathetic nervous system)**, which releases acetylcholine to act on these receptors. - This is the **most characteristic and clinically significant cardiovascular effect** of muscarinic receptor activation, making it the expected answer. *Skeletal muscle contraction* - **Skeletal muscle contraction** is mediated by **nicotinic acetylcholine receptors (nAChRs)** at the **neuromuscular junction**, NOT muscarinic receptors. - Nicotinic receptors are **ligand-gated ion channels** that cause direct depolarization and muscle contraction when activated. - This is the only option that is **NOT a muscarinic receptor action**. *Acid secretion in stomach* - **Gastric acid secretion** IS mediated by **M3 muscarinic receptors** on parietal cells. - Acetylcholine from the vagus nerve directly stimulates parietal cells and also stimulates histamine release from enterochromaffin-like cells. - While this is a valid muscarinic action, in the context of distinguishing muscarinic effects, **cardiac effects** (decreased heart rate) are more emphasized as the classic teaching point. *Salivation and lacrimation* - **Salivation and lacrimation** ARE mediated by **M3 muscarinic receptors** in exocrine glands. - These are classic parasympathetic/muscarinic effects taught in physiology. - However, when distinguishing key muscarinic actions, **M2 receptor-mediated cardiac effects** are typically highlighted as the primary cardiovascular manifestation, while M3 effects on glands are secondary teaching points.

Q: Maximum cycloplegic action of atropine is seen at ?

1-3 hours. ***1-3 hours*** - Atropine, a **non-selective muscarinic antagonist**, reaches its **peak cycloplegic effect** approximately 1 to 3 hours after topical administration. - This peak activity is crucial for accurate retinoscopy and **refractive error measurement** in children, as it effectively paralyzes the ciliary muscle. *4-6 hours* - While atropine's cycloplegic effect is still present at 4-6 hours, it is generally **past its peak action** by this time. - Slower-acting cycloplegics might have their peak around this window, but not atropine. *1-2 weeks* - The **duration of action** for atropine's cycloplegic and mydriatic effects can last for 1-2 weeks, but this is the total duration, not when the maximum action is observed. - Patients are often instructed about the **prolonged effects** and potential for blurred vision and photophobia over this period. *30-60 minutes* - While some mydriatic effects might start within 30-60 minutes, the **full cycloplegic effect** of atropine, which requires maximum paralysis of the ciliary muscle, is not achieved in this short timeframe. - Shorter-acting cycloplegics like **cyclopentolate** or **tropicamide** would show peak action within this earlier interval.

Q: Which antimuscarinic drug is used in overactive bladder?

Trospium. ***Trospium*** - **Trospium** is a quaternary ammonium compound that acts as an **antimuscarinic agent** primarily used to treat **overactive bladder (OAB)**. - Its **polar nature** limits its ability to cross the blood-brain barrier, reducing central nervous system side effects common with other antimuscarinics. *Tropicamide* - **Tropicamide** is an **antimuscarinic** agent primarily used as a **mydriatic** (to dilate pupils) and **cycloplegic** (to paralyze the ciliary muscle) for ophthalmic examinations. - It has a short duration of action, making it unsuitable for chronic conditions like overactive bladder. *Atropine* - **Atropine** is a non-selective **muscarinic antagonist** with a wide range of uses, including bradycardia, organophosphate poisoning, and ophthalmic procedures. - While it has antimuscarinic effects on the bladder, its systemic side effects (e.g., dry mouth, blurred vision, tachycardia) limit its use for overactive bladder. *Pirenzepine* - **Pirenzepine** is a selective **M1 muscarinic antagonist** primarily used to treat **peptic ulcers** by reducing gastric acid secretion. - Its selectivity for M1 receptors means it has limited efficacy for relieving bladder symptoms, which are primarily mediated by M2 and M3 receptors.

Q: What is a contraindication of antimuscarinic drugs?

Glaucoma. ***Correct: Glaucoma*** - Antimuscarinic drugs cause **mydriasis (pupil dilation)** and **cycloplegia**, which increases intraocular pressure, especially in individuals with **narrow-angle glaucoma**. - In narrow-angle glaucoma, pupil dilation causes the peripheral iris to bunch up and block the trabecular meshwork, obstructing aqueous humor outflow. - This can precipitate an **acute angle-closure glaucoma attack**, a medical emergency, making glaucoma an **absolute contraindication** to antimuscarinic drugs. - This is one of the most important contraindications to remember for all anticholinergic medications. *Incorrect: Peptic ulcer* - Antimuscarinic drugs were **historically used to treat** peptic ulcer disease by reducing gastric acid secretion and gastrointestinal motility. - While they are no longer first-line therapy (replaced by proton pump inhibitors and H2 blockers), peptic ulcer is **not a contraindication**. - The main reason they fell out of favor was due to side effects and less efficacy compared to modern alternatives, not because they worsen the condition. *Incorrect: Asthma* - Some antimuscarinics (e.g., **ipratropium, tiotropium**) are actually used as **bronchodilators** in asthma and COPD management. - They work by blocking muscarinic receptors in airway smooth muscle, causing bronchodilation. - Therefore, asthma is a **treatment indication**, not a contraindication. *Incorrect: Urinary incontinence* - Antimuscarinic drugs are the **primary pharmacological treatment** for overactive bladder and urge incontinence. - They work by blocking M3 muscarinic receptors in the detrusor muscle, reducing bladder contractions. - Common drugs include oxybutynin, tolterodine, and solifenacin. - Urinary incontinence is a **treatment indication**, not a contraindication.

Question 1

Which selective alpha-2 agonist is used in the treatment of glaucoma?

Accepted Answer

Brimonidine

Answer

Epinephrine

Answer

Dipivefrine

Answer

Timolol

Question 2

In primary open-angle glaucoma, pilocarpine eye drops lower intraocular pressure primarily by acting on which of the following?

Accepted Answer

Longitudinal fibres of the ciliary muscle

Answer

All of the options

Answer

Trabecular meshwork

Answer

Ciliary epithelium

Question 3

Hyoscine is an antagonist at which cholinergic receptor?

Accepted Answer

Muscarinic

Answer

Nicotinic

Answer

Both

Answer

None of the above

Question 4

Which sympathomimetic drug is primarily known to increase heart rate?

Accepted Answer

Isoprenaline

Answer

Phenylephrine

Answer

Noradrenaline

Answer

Adrenaline

Question 5

Which non-selective beta-blocker has sympathomimetic activity?

Accepted Answer

Pindolol

Answer

Nadolol

Answer

Acebutalol

Answer

Metoprolol

Question 6

Which anti-cholinesterase drug is known for its central nervous system activity?

Accepted Answer

Physostigmine

Answer

Edrophonium

Answer

Pyridostigmine

Answer

Neostigmine

Question 7

Which of the following is an action of muscarinic cholinergic receptors?

Accepted Answer

Decreased heart rate

Answer

Skeletal muscle contraction

Answer

Acid secretion in stomach

Answer

Salivation and lacrimation

Question 8

Maximum cycloplegic action of atropine is seen at ?

Accepted Answer

1-3 hours

Answer

1-2 weeks

Answer

4-6 hours

Answer

30-60 minutes

Question 9

Which antimuscarinic drug is used in overactive bladder?

Accepted Answer

Trospium

Answer

Atropine

Answer

Tropicamide

Answer

Pirenzepine

Question 10

What is a contraindication of antimuscarinic drugs?

Accepted Answer

Glaucoma

Answer

Peptic ulcer

Answer

Asthma

Answer

Urinary incontinence

Autonomic Nervous System Drugs — MCQs

Autonomic Nervous System Drugs — MCQs

On this page

Practice by Chapter

Want unlimited practice?